Moffitt logo

Articles related to Immunotherapy

Moffitt Announces Launch of Immunotherapy Contract Research Organization

The new organization will provide end-to-end services for pharmaceutical and biotech companies seeking to accelerate research. Read More


CRO Announcement

Moffitt Announces Launch of Immunotherapy Contract Research Organization

The new organization will provide end-to-end services for pharmaceutical and biotech companies seeking to accelerate research, Read More


Moffitt Expands TIL Therapy Research

Young sarcoma patients may benefit from tumor infiltrating lymphocyte therapy. Read More


5 Things to Know about Brain Cancer Treatments

Exploring new approaches with immunotherapy, surgery. Read More


ZUMA-3 CAR T Study Results Are In

Promise Shown in Treating Acute Lymphoblastic Leukemia Read More


Good Directions

Moffitt research associate Amber Beyer, and team are working on an adaptive cell therapy for women with HER2+ breast cancer. Read More


The Power of CAR T in Solid Tumor Treatment

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer. Read More


Moffitt Research Moves New Immunotherapy Closer to FDA Approval

Some cancer patients may be one step closer to being treated with cells from their own tumors. Read More


CAR T Therapy Safe for Older Patients

Moffitt’s closer look at clinical trial data could expand therapy’s use and effectiveness. Read More


Treating Gynecologic Cancers With Immunotherapy

Physicians and researchers are combining efforts to explore ways to harness the body’s immune system to better fight gynecologic cancers. Read More


Immunotherapy May Boost Survival in Recurrent Ovarian Cancer

Combination chemotherapy and immunotherapy treatment shows promise in recent study. Read More


FDA Approves First Immunotherapy for Breast Cancer

Patients with an aggressive form of breast cancer now have another weapon in their arsenal to fight the disease. Read More


The Monkees’ Peter Tork Had Rare Tongue Cancer

The Monkees’ bassist passed away this week. He also had a rare form of tongue cancer. Read More


Immunotherapy Shows Promise for Glioblastoma

The study marks the first time an immune-system treatment has shown any benefit to glioblastoma. Read More


New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data Read More


Is Immunotherapy the Key to Fighting Ovarian Cancer?

Oncologists believe immunotherapy could be the missing piece of the puzzle. Read More


Moffitt Uses Innovative Immunotherapy to Stand Up To (Lung) Cancer

The unique clinical trial combining two immunotherapies is funding by the Stand Up To Cancer Catalyst® Program. Read More


A New Drug Could Soon Be Available to Treat a Common Form of Skin Cancer

Nearly half of the patients who participated in the trial saw their tumors shrink. Read More



Healing Power of Sharks May Hold Cancer Clues

Research on the unique immune system of the shark may aid in the fight against cancer Read More


CAR T Drives New Ovarian Cancer Research

The new genetically-modified CAR T-cells seek out and destroy cancer cells expressing an FSH receptor protein found on a large number of ovarian cancer cells. Read More


CAR T Provides Remission, Purpose for Moffitt Leukemia Patient

For CAR T treatment, T cells are removed from a patient’s blood and sent to a lab where the cells are genetically modified to better enable them to identify and attack cancer cells. Read More


FDA Approves Second CAR T Therapy for Diffuse Large B-Cell Lymphoma

Moffitt Cancer Center is the only center in Florida to offer both FDA approved CAR T therapies, Kymriah™ and Yescarta™ Read More


Ovarian Cancer Patients May Benefit from Personalized Vaccines

Could personalized vaccines be the future of ovarian cancer treatment? Read More


Immunotherapy Key to Unlocking Lung Cancer Survival

A recent study represents another step forward in immunotherapy, which has been making steady gains in recent years. Read More


Third Grade Friends Hold Bake Sale to Raise Money for Cancer Research

The two students mailed a handwritten note to Dr. Frederick Locke, the CAR T investigator at Moffitt, to "use the money we made at our bake sale to help find better treatments or even a cure for cancer." Read More


Cell Therapies TIL

Moffitt Expands TIL Therapy Research

Young sarcoma patients may benefit from tumor infiltrating lymphocyte therapy. Read More


Ascobrain

5 Things to Know about Brain Cancer Treatments

Exploring new approaches with immunotherapy, surgery. Read More


Acute Lymphoblastic Leukemia

ZUMA-3 CAR T Study Results Are In

Promise Shown in Treating Acute Lymphoblastic Leukemia Read More


Breast Imaging Scan 2

Good Directions

Moffitt research associate Amber Beyer, and team are working on an adaptive cell therapy for women with HER2+ breast cancer. Read More


CAR T Solid Tumors ASCO (1)

The Power of CAR T in Solid Tumor Treatment

CAR T therapy involves a patient’s own T cells that have been genetically engineered to target a patient’s own specific cancer. Read More


Britta Beningfield Immunotherapy

Moffitt Research Moves New Immunotherapy Closer to FDA Approval

Some cancer patients may be one step closer to being treated with cells from their own tumors. Read More


Older CAR T Patients

CAR T Therapy Safe for Older Patients

Moffitt’s closer look at clinical trial data could expand therapy’s use and effectiveness. Read More


GYN Cancer Immunotherapy

Treating Gynecologic Cancers With Immunotherapy

Physicians and researchers are combining efforts to explore ways to harness the body’s immune system to better fight gynecologic cancers. Read More


Breast Cells

Combining Immunotherapy in Triple Negative Breast Cancer Treatment

Responses have been seen in some patients with triple-negative breast cancer (TNBC), signaling a potential role for immunotherapy in this tumor type. Read More


Breast Cancer Immunotherapy

FDA Approves First Immunotherapy for Breast Cancer

Patients with an aggressive form of breast cancer now have another weapon in their arsenal to fight the disease. Read More


Mccain Glioblastoma Immunotherapy

Immunotherapy Shows Promise for Glioblastoma

The study marks the first time an immune-system treatment has shown any benefit to glioblastoma. Read More


DrLocke-with-patient.jpg

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data Read More


Pam-Griffith-LATTE.jpg

Immunotherapy Clinical Trial Brought Renewed Hope To Lung Cancer Patient

My husband and I celebrated our 50th wedding anniversary last year and know without a doubt that I would not be alive today if we had not sought treatment at Moffitt Cancer Center. Read More


Immontherapy-Pipette-Cells-Cropped.jpg

Is Immunotherapy the Key to Fighting Ovarian Cancer?

Oncologists believe immunotherapy could be the missing piece of the puzzle. Read More


SU2C.jpg

Moffitt Uses Innovative Immunotherapy to Stand Up To (Lung) Cancer

The unique clinical trial combining two immunotherapies is funding by the Stand Up To Cancer Catalyst® Program. Read More



Bonnethead-Shark.jpg

Healing Power of Sharks May Hold Cancer Clues

Research on the unique immune system of the shark may aid in the fight against cancer Read More


CAR T Leukemia Cell.jpg

CAR T Drives New Ovarian Cancer Research

The new genetically-modified CAR T-cells seek out and destroy cancer cells expressing an FSH receptor protein found on a large number of ovarian cancer cells. Read More


IMG_32161.jpg

CAR T Provides Remission, Purpose for Moffitt Leukemia Patient

For CAR T treatment, T cells are removed from a patient’s blood and sent to a lab where the cells are genetically modified to better enable them to identify and attack cancer cells. Read More


marjorie-family.jpg

Immunotherapy Key to Unlocking Lung Cancer Survival

A recent study represents another step forward in immunotherapy, which has been making steady gains in recent years. Read More


lung-cancer-research-640.jpg

Moffitt’s Top Research Developments of 2017: Novel Combination Approach to Lung Cancer Wins Moffitt a Stand Up To Cancer Grant

The second one on the list of Moffitt research developments involves a grant to study how immunotherapy can change the way the cancer center is treating lung cancer. Read More


Locke-research-lab.jpg

Moffitt’s Top Research Developments of 2017: CAR T Therapy Tested, Commercially Available at Moffitt

The first one on the list of Moffitt's top research developments for 2017 is the FDA approval of CAR T therapy for certain aggressive types of adult lymphoma. Read More


CART-Cell-Illustration-640.jpg

Moffitt Treats First U.S. Patient with Newly FDA-Approved CAR T Therapy

Moffitt has treated the first U.S. adult lymphoma patient with a therapy formerly available only through clinical trials. Read More


CART-teaser.jpeg

Infographic: How CAR T Therapy Works to Fight Cancer

CAR T therapy, a groundbreaking new treatment, utilizes the body’s own immune system to fight cancer. Read More


CART-lab-640.jpg

What is CAR T Therapy?

Dr. Frederick Locke, vice chair of the Department of Blood and Marrow Transplant and Cellular Immunotherapy, answers some frequently asked questions about CAR T cell therapy. Read More


DrFredLocke-CART-640.jpg

CAR T Cancer Therapy a ‘Huge Breakthrough’ for Patients with Lymphoma

Moffitt patients with an aggressive type of lymphoma were among the first to benefit in clinical trials of a groundbreaking therapy. Read More


Abate-Daga-Spotlight-640.jpg

Research Spotlight: Dr. Abate-Daga Discusses the Progress of Immunotherapy

Dr. Daniel Abate-Daga's research is focused on the development of T cell-based immunotherapies for the treatment of cancer. Read More


Locke-blog.jpg

Dr. Locke: CAR-T Cell Therapy a 'Revolution in Cancer Care'

Dr. Locke, the principal investigator for a new experimental immunotherapy called CAR T-cell therapy, talks about the breakthroughs with this type of treatment. Read More


COMMUNITY OF COURAGE

STORIES TO INSPIRE YOU ON YOUR JOURNEY THROUGH CANCER